Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Aguado

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|January 6, 2025
Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritisAlan McWilliam, Deborah Marshall, Sarah L Kerns, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy ToxicityGillian C Barnett, Sarah L Kerns, Leila Dorling, et al.
Frontiers in Oncology|November 20, 2020
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast CohortTim Rattay, Petra Seibold, Miguel E Aguado-Barrera, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Frontiers in Oncology|November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancerNuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Journal of the National Cancer Institute|May 17, 2019
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer RadiotherapySarah L Kerns, Laura Fachal, Leila Dorling, et al.
Health and Quality of Life Outcomes|November 29, 2025
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapyElke Rammant, Emile Deman, Valérie Fonteyne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate CancerManzur Farazi, Xin Yang, Carson J Gehl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|January 6, 2025
Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritisAlan McWilliam, Deborah Marshall, Sarah L Kerns, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2022
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy ToxicityGillian C Barnett, Sarah L Kerns, Leila Dorling, et al.
Frontiers in Oncology|November 20, 2020
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast CohortTim Rattay, Petra Seibold, Miguel E Aguado-Barrera, et al.
Nature Communications|April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patientsPhilipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Frontiers in Oncology|November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancerNuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Journal of the National Cancer Institute|May 17, 2019
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer RadiotherapySarah L Kerns, Laura Fachal, Leila Dorling, et al.
Health and Quality of Life Outcomes|November 29, 2025
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapyElke Rammant, Emile Deman, Valérie Fonteyne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2025
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate CancerManzur Farazi, Xin Yang, Carson J Gehl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2023
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancerHarkeran K Jandu, Colin D Veal, Laura Fachal, et al.
Pageof 9